| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/08/2000 | WO2000051685A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | WO2000051616A1 Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives |
| 09/08/2000 | WO2000051597A1 Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO1999034784A3 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 09/08/2000 | CA2364914A1 N-substituted benzoyl indoles as estrogenic agents |
| 09/08/2000 | CA2364878A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2364127A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| 09/08/2000 | CA2363077A1 Methods for targeting rna molecules |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/06/2000 | EP1033364A1 Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032584A1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 09/06/2000 | EP1032578A1 Novel methylenebisphosphonic acid derivatives |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032386A1 Use of oxazolidinone derivatitives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels |
| 09/06/2000 | CN1265585A (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 09/06/2000 | CN1265319A Medicine for dredging the meridian passage and softening mass and its preparation |
| 09/06/2000 | CN1265318A Xiancaoteng capsule made of korean epimedium herb, liquorice root and common threewingnut root and its preparation |
| 09/06/2000 | CN1265316A Kidney-invigorating and bone strengthening capsule |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056083C Method and compositions for treatment and repair of defects or lesions in cartilage |
| 09/06/2000 | CN1056081C Medicine for curing severe bone flourosis and production method thereof |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114360 Pyrrole compounds |
| 09/05/2000 | US6114333 2-Pyrimidineamine derivatives and processes for their preparation |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114316 Combination of bisphosphonate and tetracycline |
| 08/31/2000 | WO2000050872A2 A system for cell-based screening |
| 08/31/2000 | WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 08/31/2000 | WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease |
| 08/31/2000 | WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
| 08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | WO2000050441A1 Novel substituted 11.beta steroid derivatives, method for preparing same and intermediates of said method, use as medicine and compositions containing them |
| 08/31/2000 | WO2000050408A1 Pyridazin-3-one derivatives and medicines containing the same |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000050395A1 Sulfonamide-containing indole compounds |
| 08/31/2000 | WO2000050045A2 Solution for injection containing a gold compound, calendula and belladonna extracts for the treatment of arthroses |
| 08/31/2000 | WO2000033667A3 Bioflavonoids, anthocyanins and phenol compounds from cherries as antioxidants |
| 08/31/2000 | WO2000018932A9 Receptor based antagonists and methods of making and using |
| 08/31/2000 | WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 08/31/2000 | WO2000007996A3 Pyrazoles as estrogen receptor modulators |
| 08/31/2000 | DE19908441C1 Injektionslösung zur Behandlung von Arthrosen Solution for injection for treatment of arthrosis |
| 08/31/2000 | CA2363621A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
| 08/31/2000 | CA2362533A1 Gene sequence variations with utility in determining the treatment of disease |
| 08/31/2000 | CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection |
| 08/30/2000 | EP1031575A1 Process for preparing growth hormone secretagogues |
| 08/30/2000 | EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/30/2000 | EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030842A1 Metalloproteinase inhibitors |
| 08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
| 08/30/2000 | EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030835A2 Urea derivatives and their use as integrin inhibitors |
| 08/30/2000 | EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS |
| 08/30/2000 | EP1030658A1 Method of building and maintaining bone |
| 08/30/2000 | EP0612246B1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/30/2000 | CN1265096A Hydrazine derivatives |
| 08/30/2000 | CN1265035A Method for inhibiting bone resorption |
| 08/30/2000 | CN1055862C Chinese medicine prepn. for curing osteonescrosis |
| 08/30/2000 | CN1055860C Wine for curing bone impediment and rheumatic pain |
| 08/30/2000 | CN1055854C Bone knitting powder |
| 08/30/2000 | CN1055853C Chiense drug for treating osteoporosis |
| 08/30/2000 | CN1055845C Powder for treating fracture and injury |
| 08/30/2000 | CN1055842C Drug for traumatic injuries and its prepn. method |
| 08/30/2000 | CN1055835C Lianhuangsong pill and capsule and its prepn. method |
| 08/30/2000 | CN1055834C Quick results detumescence pain stop paste and preparing process |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer |
| 08/29/2000 | US6110960 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents |
| 08/29/2000 | US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing |
| 08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 08/29/2000 | US6110913 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | CA2157879C Methods for inhibiting bone loss with 3,4-diarylchroman |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |